File:DNIC structure.svgStructure of a dinitrosyliron complex (DNIC)
In biochemistry, dinitrosyl iron complexes (DNIC's) are coordination complexes with the formula [Fe(NO)2(SR)2]−. Together with Roussin esters (Fe2(NO)4(SR)2), they result from the degradation of iron-sulfur proteins by nitric oxide. Commonly the thiolate ligands are cysteinyl residues or glutathione. These metal nitrosyl complexes have attracted much attention because they serve as biochemical signals in response to oxidative stress, manifested in the formation of NO. The anions are tetrahedral.[1][2]
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
|
|---|
| Forms | |
|---|
| Targets | |
|---|
NO donors
(prodrugs) | |
|---|
Enzyme
(inhibitors) | |
|---|
| Others |
- Indirect/downstream NO modulators: ACE inhibitors/AT-II receptor antagonists (e.g., captopril, losartan)
- ETB receptor antagonists (e.g., bosentan)
- L-Type calcium channel blockers (e.g., dihydropyridines: nifedipine)
- Nebivolol (beta blocker)
- PDE5 inhibitors (e.g., sildenafil)
- non-selective PDE inhibitors (e.g., caffeine)
- PDE9 inhibitors (e.g., paraxanthine)
- cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil)
- Statins (e.g., simvastatin)
|
|---|
|
